SCHEMBL94975

SCHEMBL94975

CC(=O)CCC[O]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL96499 0.90 — —
SCHEMBL2525606 0.88 PAOX (0.59) —
SCHEMBL506038 0.88 PAOX (0.59) —
SCHEMBL28338247 0.88 PAOX (0.59) —
SCHEMBL45340 0.88 — —
SCHEMBL620309 0.82 ALDH1A1 (0.69) —
SCHEMBL988309 0.82 — —
SCHEMBL95615 0.79 — —
SCHEMBL316713 0.79 PAOX (0.72) —
Calcium SCHEMBL11375342 0.79 ALDH1A1 (0.64) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021081881-A1 FUNCTIONAL CARBOHYDRATE MOLECULE BASED ON TDG MOLECULAR SCAFFOLD, AND PREPARATION METHOD THEREFOR 深圳先进技术研究院 2021-05-06 — — WO claimed
US-8461135-B2 Boron-containing small molecules as anti-inflammatory agents ANACOR PHARMACEUTICALS, INC. (US) 2013-06-11 — — US claimed
US-8039450-B2 Boron-containing small molecules as anti-inflammatory agents ANACOR PHARMACEUTICALS, INC. (US) 2011-10-18 — — US claimed
EP-0621282-B1 3-Deoxyoligosaccharides, process for their preparation and pharmaceutical compositions containing them SANOFI SA (FR) 1997-07-09 — — EP claimed
EP-0621282-A1 3-Deoxyoligosaccharides, process for their preparation and pharmaceutical compositions containing them ELF SANOFI (FR) 1994-10-26 — — EP claimed
WO-2023176773-A1 METHOD FOR PRODUCING CHIMERIC MOLECULE 国立大学法人東北大学 2023-09-21 — — WO disclosed
CN-109328237-B Inhibitors of PAPD5 and PAPD7 for the treatment of hepatitis b infection 豪夫迈·罗氏有限公司 2022-12-06 — — CN disclosed
WO-2021081881-A1 FUNCTIONAL CARBOHYDRATE MOLECULE BASED ON TDG MOLECULAR SCAFFOLD, AND PREPARATION METHOD THEREFOR 深圳先进技术研究院 2021-05-06 — — WO disclosed
CN-107459544-B Substituted nucleosides, nucleotides and analogs thereof 詹森生物制药有限公司 2021-03-16 — — CN disclosed
CN-105408341-B Substituted nucleosides, nucleotide and the like 艾丽奥斯生物制药有限公司 2019-06-21 — — CN disclosed
CN-107459544-A Substituted nucleosides, nucleotides and the like 艾丽奥斯生物制药有限公司 2017-12-12 — — CN disclosed
CN-104114568-B Substituted nucleosides, nucleotides and analogs thereof 艾丽奥斯生物制药有限公司 2017-09-01 — — CN disclosed
EP-0882715-A1 NOVEL N-(UNSUBSTITUTED OR SUBSTITUTED)-4-SUBSTITUTED-6-(UNSUBSTITUTED OR SUBSTITUTED)PHENOXY-2-PYRIDINECARBOXAMIDES OR THIOCARBOXAMIDES, PROCESSES FOR PRODUCING THE SAME, AND HERBICIDES KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1998-12-09 — — EP disclosed
EP-0873990-A1 BENZOIC ACID COMPOUNDS AND MEDICINAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-10-28 — — EP disclosed
EP-0835248-A1 1-AMINO-3-BENZYLURACILS BASF AKTIENGESELLSCHAFT (DE) 1998-04-15 — — EP disclosed
EP-0621282-B1 3-Deoxyoligosaccharides, process for their preparation and pharmaceutical compositions containing them SANOFI SA (FR) 1997-07-09 — — EP disclosed
EP-0774460-A1 BENZOIC ACID COMPOUND AND USE THEREOF AS MEDICINE YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1997-05-21 — — EP disclosed
WO-1997001543-A1 1-AMINO-3-BENZYLURACILS BASF AKTIENGESELLSCHAFT (DE) 1997-01-16 — — WO disclosed
EP-0621282-A1 3-Deoxyoligosaccharides, process for their preparation and pharmaceutical compositions containing them ELF SANOFI (FR) 1994-10-26 — — EP disclosed
US-4309432-A TOPICAL ADMINISTRATION OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) 1982-01-05 — — US disclosed
Send feedback